Riverview Acquisition Corp. (NASDAQ:RVAC) announced in an 8-K filing this afternoon that about 73.5% of its shares were redeemed ahead of its vote to complete its combination with coffee and tea supplier Westrock Coffee.
This marks August’s best redemption result followed by Software Acquisition Group III’s combination with Nogin which saw 82.7% redeemed earlier this week. Both of these votes fall below the average redemption rate of 88.1% for the third quarter.
Riverview originally brought about $250 million into the deal from its trust, along with $250 million in common stock PIPE commitments at $10 per share. The PIPE is funded by $60 million from R. Brad Martin, NFC Investments, LLC, and the other Riverview founders, $25 million from Westrock Coffee founders, and $78 million each from HF Capital, the Haslam family investment office, and funds managed by Southeastern Asset Management.
Westrock Coffee was also able to secure financing from Wells Fargo for a $300 million senior secured credit facility to be entered into at closing, which will be used to re-finance existing debt and fund the company’s expansion plans.
Westrock Coffee is expected to trade on the Nasdaq under the symbol “WEST” following the deal’s close.
The parties initially announced the $1.1 billion combination on April 4. Little Rock, Arkansas-based Westrock Coffee supplies innovative coffee, tea, flavors, extracts, and ingredients products to retail, food service and restaurant, convenience store, and hospitality industries around the world.
Blue Ocean (NASDAQ:BOCN) provided significantly more texture today in the presentation for its $275 million combination with Asian digital media group TNL Mediagene, which it expects to hit profitability in the second half of the year despite a slight shakeup in financing for the transaction. The first big update in the first investor deck is...
At the SPAC of Dawn A brand new market may have just opened up for space de-SPACs as NASA administrator Bill Nelson announced a shift in the agency’s $11 billion program for a mission to return samples from Mars. Rather than rely on the agency’s internal technologies that would be predicted to get a sample...
Overall deal flow between SPACs and biotech firms has slowed over the last year, but some pending FDA changes could breathe new life into particular business models within the space. In particular, the FDA has asked Congress as part of its 2025 Legislative Proposals to eliminate the interchangeability designation for biosimilar medications, claiming the existing...
At the SPAC of Dawn Ever since Digital World announced its combination with Trump Media (NASDAQ:DJT) back in October 2021, it was clear that SPACworld and the Trump show were set to be intertwined for quite some time. And, although not every headline has a bearing on the wider SPAC world, Trump Media’s post-close rise...
AltC (NYSE:ALCC) has reportedly been taking the pitch deck for its combination with nuclear fission firm Oklo on the road in recent weeks, which has generated the rare result of a SPAC trading significantly above its trust value still well before completing its deal. The SPAC has an estimated $10.59 per share in its trust...